Ozbek Ahmet, Algın Abdullah, Tas Gokhan, Erdogan Mehmet Ozgur
Department of Emergency Medicine, University of Health Sciences Sisli Etfal Training and Research Hospital, Istanbul, Turkey.
Department of Emergency Medicine, University of Health Sciences Umraniye Training and Research Hospital, Istanbul, Turkey.
Emerg Med Int. 2020 Jan 31;2020:6328037. doi: 10.1155/2020/6328037. eCollection 2020.
In patients with CKD, cTn concentrations may be elevated in the absence of AMI, which is a predicted finding caused by chronic structural heart disease rather than acute injury. The increase in troponin level observed in noncardiac conditions provides conflicting results when predicting mortality. Low lactate clearance was associated with increased mortality. Lactate clearance is calculated as follows: (early lactate - late lactate/early lactate) 100. We aimed to investigate whether troponin clearance calculated according to this formula had an effect on short-term mortality.
The study included 300 patients with chronic renal failure who had a sepsis-related organ failure assessment (SOFA) score ≥3. By taking the baseline troponin at the time of emergency presentation as reference and comparing them with the fourth-hour troponin values, troponin clearance was investigated in the evaluation of mortality among hospitalized patients with CKD within the first month after discharge. The data obtained were analyzed using the SPSS data analysis software version 20.0. Student's -test was used for the parametric data, and the Chi-squared test for the nonparametric data.
Of the 300 patients evaluated, 189 patients survived (mean age 66.20 ± 14.597 years), and 111 died (mean age 74.81 ± 12.916 years). Troponin clearance was detected in 40 of the 111 patients in the mortality group and 119 of the 189 patients in the survival group. Troponin clearance was significantly more frequent in surviving patients (=0.0000083).
Troponin clearance can be considered as a valuable leading indicator of survival, but higher levels of troponin clearance did not lead to higher survival rates.
在慢性肾脏病(CKD)患者中,肌钙蛋白(cTn)浓度可能在无急性心肌梗死(AMI)的情况下升高,这是由慢性结构性心脏病而非急性损伤导致的预期结果。在非心脏疾病中观察到的肌钙蛋白水平升高在预测死亡率时产生了相互矛盾的结果。低乳酸清除率与死亡率增加相关。乳酸清除率的计算方法如下:(早期乳酸值 - 晚期乳酸值/早期乳酸值)×100。我们旨在研究根据此公式计算的肌钙蛋白清除率是否对短期死亡率有影响。
该研究纳入了300例脓毒症相关器官功能衰竭评估(SOFA)评分≥3的慢性肾衰竭患者。以急诊就诊时的基线肌钙蛋白为参照,将其与第4小时的肌钙蛋白值进行比较,在出院后第一个月内对住院的CKD患者进行死亡率评估时研究肌钙蛋白清除率。使用SPSS 20.0版数据分析软件对获得的数据进行分析。参数数据采用Student's t检验,非参数数据采用卡方检验。
在评估的300例患者中,189例存活(平均年龄66.20±14.597岁),111例死亡(平均年龄74.81±12.916岁)。死亡组111例患者中有40例检测到肌钙蛋白清除,存活组189例患者中有119例检测到肌钙蛋白清除。存活患者的肌钙蛋白清除率明显更高(P = 0.0000083)。
肌钙蛋白清除率可被视为生存的有价值的领先指标,但较高水平的肌钙蛋白清除率并未导致更高的生存率。